Form 4: Director Acquires US Physical Therapy Shares

Anne Motsenbocker, a Director at U.S. Physical Therapy Inc., acquired 2,306 shares of common stock on May 19, 2026, as part of a restricted stock grant.

Summary

• Director Anne Motsenbocker acquired 2,306 shares of U.S. Physical Therapy Inc. common stock on May 19, 2026.
• The acquisition was made through a restricted stock grant under the Company's Amended and Restated 2003 Stock Incentive Plan.
• The shares were acquired at a price of $61.61 per share.
• Following this transaction, Motsenbocker beneficially owns 9,812 shares of common stock.
• Restrictions on 1,153 shares will lapse on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, provided she remains a director on those dates.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction (restricted stock grant) without providing new financial performance data or strategic updates.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• Restricted stock grants align management and director incentives with long-term shareholder value.
• The acquisition increases the director's direct beneficial ownership.

Risks

• Vesting of restricted stock is contingent on continued directorship, introducing a potential risk of forfeiture if the director's tenure ends before vesting dates.
• The stock price at the time of grant ($61.61) may not reflect current market conditions or future performance.

Future Outlook

The future outlook is tied to the vesting of restricted stock, which is dependent on the director's continued service. The company's overall future outlook is not detailed in this specific filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly director acquisitions, are closely watched by the market as potential indicators of management's confidence in the company's valuation and future performance within the physical therapy and healthcare services sector.

Stakeholder Impact

• Shareholders: May view director stock acquisition positively as a sign of confidence, but the transaction itself does not directly impact share price or dividends.
• Employees: The restricted stock plan is part of the compensation structure for key personnel, including directors.
• Management: The transaction is part of the compensation and incentive framework for the director.

Next Steps

• Monitor the vesting of the restricted stock shares on August 20, 2026, November 20, 2026, and March 6, 2027.
• Observe any future insider transactions by Anne Motsenbocker or other company insiders.

Key Dates

Keywords

U.S. Physical Therapy Inc., USPH, Form 4, Insider Trading, Stock Grant, Restricted Stock, Director, Beneficial Ownership, SEC Filing